📈 Stocks · US

AVO

Mission Produce
Stocks US
Overall assessment · Trend now + news, 30 days ?
▬ Neutral weak Confidence 3 % ?
News situation · 1 items / 30 D
▬ Neutral weak 3 %
1.0 Impact / 10
By source type
Release 1

1 of 1 straight from the issuer or regulator

News, 30 days
Neutral
Signal history

Both worlds over time

Technical and news signals of the last 90 days on one timeline.

Bullish ▲Bearish ▼10.09. · News signal · Impact 10/1011.09. · News signal · Impact 8/1029.10. · News signal · Impact 1/10
90 days ago today
Technical signal News signal Size = strength
Fundamental outlook

AVO fundamental outlook?

From news analysis — different time windows than the trading horizons above

  • AVO reported Q3 adjusted EBITDA of $32.4 million, surpassing expectations and highlighting strong operational performance.
  • The company raised its annualized cost synergy estimate from the Calavo acquisition to over $30 million, up from $25 million, reflecting successful integration.
  • Seasonal Peru avocado and blueberry harvests are expected to drive Q4 EBITDA, providing a clear catalyst for the next quarter.
  • Management highlighted increased retail market share and superior productivity from vertically integrated farming operations in Peru as key growth drivers.
  • The recent SVP appointment is a routine leadership change with minimal market impact, keeping short-term sentiment neutral.
  • Risks include increased interest expense from acquisition debt and potential integration challenges during facility consolidation.
  • Structural advantages such as vertical integration and strong demand trends support a bullish long-term outlook.

In Q3 2026, Mission Produce (AVO) delivered a strong financial performance, with adjusted EBITDA of $32.4 million, beating expectations and driven by successful integration of the Calavo acquisition. Management raised its cost synergy target to over $30 million annually, up from $25 million, and highlighted robust avocado demand, which boosts retail market share. The announcement on 2026-09-09 also noted seasonal Peru avocado and blueberry harvests as catalysts for Q4 EBITDA. On 2026-10-29, AVO appointed Michelle Wieczorek as SVP of Clinical Sales Enablement, a routine leadership hire with minimal direct market impact, contributing to a neutral short-term sentiment. The mid-term outlook remains bullish (confidence 65%) due to continued integration synergies and seasonal harvests, while the long-term view is also bullish (confidence 70%) as structural drivers like vertical integration and retail expansion support sustained growth, though higher interest expenses from debt present a risk.

15 min ago · Based on 3 signals

1–7 days Neutral

In the next 1-7 days, AVO is likely to trade sideways to slightly positive, as the market digests the leadership appointment with no major catalysts. Watch for any follow-up news on integration or price movements around $30-$32, with support near recent lows.

1–4 weeks Bullish

Over the next 1-4 weeks, AVO is expected to benefit from continued execution of Calavo synergies and seasonal harvests, supporting a modest upward trend. The raised synergy target and robust demand should keep fundamentals strong, though any negative surprises on integration costs could cap gains.

1–3 months Bullish

In the next 1-3 months, AVO's structural advantages—vertical integration, expanding retail presence, and strong avocado demand—are likely to drive sustained EBITDA growth. The raised synergy targets and seasonal tailwinds provide a solid foundation, though higher interest expenses and integration risks remain key factors to monitor.

Economic data for AVO

Full calendar

Recently released

  • TodayUSDPCE Price Index y/y●●●Forecast 3.3%Previous 3.4%10 min ago
  • TodayUSDPCE Price Index m/m●●●Forecast 0.4%Previous 0.3%10 min ago
  • TodayUSDCore PCE Price Index y/y●●●Forecast 3.1%Previous 3.0%10 min ago
  • TodayUSDCore PCE Price Index m/m●●●Forecast 0.2%Previous 0.2%10 min ago
  • TodayUSDGDP Sales q/q●●●Forecast 2.7%Previous 2.8%10 min ago
  • TodayUSDInitial Jobless Claims●●●Forecast 199KPrevious 194K10 min ago
  • TodayUSDGDP q/q●●●Forecast 1.4%Previous 2.2%10 min ago
  • October 28, 2026USDFOMC Press Conference●●●18 h ago

Coming up

  • November 2, 2026USDISM Manufacturing Prices Paid●●●Forecast 80.7Previous 77.9in 4 days
  • November 2, 2026USDISM Manufacturing PMI●●●Forecast 54.7Previous 54.5in 4 days
  • November 3, 2026USDJOLTS Job Openings●●●Forecast 6.779MPrevious 7.079Min 5 days
  • November 4, 2026USDADP Nonfarm Employment Change●●●Forecast 64KPrevious 90Kin 6 days
  • November 4, 2026USDISM Non-Manufacturing Prices Paid●●●Forecast 69.5Previous 74.0in 6 days
  • November 4, 2026USDISM Non-Manufacturing PMI●●●Forecast 55.2Previous 54.9in 6 days
  • November 4, 2026USDEIA Crude Oil Stocks Change●●●in 6 days

All times UTC. Assessed against the consensus forecast, otherwise against the previous value.

News, 30 days

What is being reported about AVO

Asset Snapshot

📝 Overview Generated automatically?

AVO has been the subject of 3 signals across 3 articles in the last 365 days. Sentiment skews Bullish (67%).

Breakdown: 2 bullish, 0 bearish, 1 neutral. AI confidence averages 64% across all signals.

Most-cited catalysts: Increased annualized synergy targets from $25 million to over $30 million (1×), Seasonal Peru avocado and blueberry harvests expected to drive Q4 EBITDA (1×). Most-cited risk factors: Increased interest expense due to debt used for the Calavo acquisition (1×), Potential for integration challenges or 'dis-synergies' during facility and technology consolidation (1×).